메뉴 건너뛰기




Volumn 2, Issue 9, 2010, Pages 325-336

Current concepts on cytomegalovirus infection after liver transplantation

Author keywords

Cytomegalovirus; Hepatitis; Outcome; Prophylaxis; Transplantation; Treatment; Valganciclovir

Indexed keywords


EID: 79961030252     PISSN: None     EISSN: 19485182     Source Type: Journal    
DOI: 10.4254/wjh.v2.i9.325     Document Type: Article
Times cited : (40)

References (92)
  • 1
    • 11244335482 scopus 로고    scopus 로고
    • Management of CMV infection and disease in transplant patients. 27-29 February 2004
    • Razonable RR, Emery VC. Management of CMV infection and disease in transplant patients. 27-29 February 2004. Herpes 2004; 11: 77-86
    • (2004) Herpes , vol.11 , pp. 77-86
    • Razonable, R.R.1    Emery, V.C.2
  • 2
    • 0347285458 scopus 로고    scopus 로고
    • Herpesvirus infections in transplant recipients: current challenges in the clinical management of cytomegalovirus and Epstein-Barr virus infections
    • Razonable RR, Paya CV. Herpesvirus infections in transplant recipients: current challenges in the clinical management of cytomegalovirus and Epstein-Barr virus infections. Herpes 2003; 10: 60-65
    • (2003) Herpes , vol.10 , pp. 60-65
    • Razonable, R.R.1    Paya, C.V.2
  • 4
    • 0031581506 scopus 로고    scopus 로고
    • Randomised trial of efficacy and safety of oral ganciclovir in the prevention of cytomegalovirus disease in liver-transplant recipients. The Oral Ganciclovir International Transplantation Study Group [corrected]
    • Gane E, Saliba F, Valdecasas GJ, O'Grady J, Pescovitz MD, Lyman S, Robinson CA. Randomised trial of efficacy and safety of oral ganciclovir in the prevention of cytomegalovirus disease in liver-transplant recipients. The Oral Ganciclovir International Transplantation Study Group [corrected]. Lancet 1997; 350: 1729-1733
    • (1997) Lancet , vol.350 , pp. 1729-1733
    • Gane, E.1    Saliba, F.2    Valdecasas, G.J.3    O'Grady, J.4    Pescovitz, M.D.5    Lyman, S.6    Robinson, C.A.7
  • 6
    • 0037090071 scopus 로고    scopus 로고
    • Definitions of cytomegalovirus infection and disease in transplant recipients
    • Ljungman P, Griffiths P, Paya C. Definitions of cytomegalovirus infection and disease in transplant recipients. Clin Infect Dis 2002; 34: 1094-1097
    • (2002) Clin Infect Dis , vol.34 , pp. 1094-1097
    • Ljungman, P.1    Griffiths, P.2    Paya, C.3
  • 8
    • 0024462242 scopus 로고
    • Cytomegalovirus hepatitis in liver transplantation: prospective analysis of 93 consecutive orthotopic liver transplantations
    • Paya CV, Hermans PE, Wiesner RH, Ludwig J, Smith TF, Rakela J, Krom RA. Cytomegalovirus hepatitis in liver transplantation: prospective analysis of 93 consecutive orthotopic liver transplantations. J Infect Dis 1989; 160: 752-758
    • (1989) J Infect Dis , vol.160 , pp. 752-758
    • Paya, C.V.1    Hermans, P.E.2    Wiesner, R.H.3    Ludwig, J.4    Smith, T.F.5    Rakela, J.6    Krom, R.A.7
  • 10
    • 33645643970 scopus 로고    scopus 로고
    • Strategies to prevent organ disease by cytomegalovirus in solid organ transplant recipients
    • author reply 457
    • Singh N, Wagener MM. Strategies to prevent organ disease by cytomegalovirus in solid organ transplant recipients. Ann Intern Med 2006; 144: 456-457; author reply 457
    • (2006) Ann Intern Med , vol.144 , pp. 456-457
    • Singh, N.1    Wagener, M.M.2
  • 11
    • 21044446686 scopus 로고    scopus 로고
    • Who among cytomegalovirus-seropositive liver transplant recipients is at risk for cytomegalovirus infection?
    • Singh N, Wannstedt C, Keyes L, Wagener MM, Cacciarelli TV. Who among cytomegalovirus-seropositive liver transplant recipients is at risk for cytomegalovirus infection? Liver Transpl 2005; 11: 700-704
    • (2005) Liver Transpl , vol.11 , pp. 700-704
    • Singh, N.1    Wannstedt, C.2    Keyes, L.3    Wagener, M.M.4    Cacciarelli, T.V.5
  • 12
    • 17444431146 scopus 로고    scopus 로고
    • Epidemiology of cytomegalovirus disease in solid organ and hematopoietic stem cell transplant recipients
    • Razonable RR. Epidemiology of cytomegalovirus disease in solid organ and hematopoietic stem cell transplant recipients. Am J Health Syst Pharm 2005; 62: S7-S13
    • (2005) Am J Health Syst Pharm , vol.62
    • Razonable, R.R.1
  • 13
    • 0035576910 scopus 로고    scopus 로고
    • Allograft rejection predicts the occurrence of late-onset cytomegalovirus (CMV) disease among CMV-mismatched solid organ transplant patients receiving prophylaxis with oral ganciclovir
    • Razonable RR, Rivero A, Rodriguez A, Wilson J, Daniels J, Jenkins G, Larson T, Hellinger WC, Spivey JR, Paya CV. Allograft rejection predicts the occurrence of late-onset cytomegalovirus (CMV) disease among CMV-mismatched solid organ transplant patients receiving prophylaxis with oral ganciclovir. J Infect Dis 2001; 184: 1461-1464
    • (2001) J Infect Dis , vol.184 , pp. 1461-1464
    • Razonable, R.R.1    Rivero, A.2    Rodriguez, A.3    Wilson, J.4    Daniels, J.5    Jenkins, G.6    Larson, T.7    Hellinger, W.C.8    Spivey, J.R.9    Paya, C.V.10
  • 14
    • 28944437676 scopus 로고    scopus 로고
    • Infections and allograft rejection - intertwined complications of organ transplantation
    • Razonable RR, Paya CV. Infections and allograft rejection - intertwined complications of organ transplantation. Swiss Med Wkly 2005; 135: 571-573
    • (2005) Swiss Med Wkly , vol.135 , pp. 571-573
    • Razonable, R.R.1    Paya, C.V.2
  • 15
    • 0023676404 scopus 로고
    • Cytomegalovirus infection and donor/recipient HLA antigens: interdependent co-factors in pathogenesis of vanishing bileduct syndrome after liver transplantation
    • O'Grady JG, Alexander GJ, Sutherland S, Donaldson PT, Harvey F, Portmann B, Calne RY, Williams R. Cytomegalovirus infection and donor/recipient HLA antigens: interdependent co-factors in pathogenesis of vanishing bileduct syndrome after liver transplantation. Lancet 1988; 2: 302-305
    • (1988) Lancet , vol.2 , pp. 302-305
    • O'Grady, J.G.1    Alexander, G.J.2    Sutherland, S.3    Donaldson, P.T.4    Harvey, F.5    Portmann, B.6    Calne, R.Y.7    Williams, R.8
  • 16
    • 0026059840 scopus 로고
    • Severe ductopenic rejection with features of vanishing bile duct syndrome: clinical, biochemical, and histologic evidence for spontaneous resolution
    • Noack KB, Wiesner RH, Batts K, van Hoek B, Ludwig J. Severe ductopenic rejection with features of vanishing bile duct syndrome: clinical, biochemical, and histologic evidence for spontaneous resolution. Transplant Proc 1991; 23: 1448-1451
    • (1991) Transplant Proc , vol.23 , pp. 1448-1451
    • Noack, K.B.1    Wiesner, R.H.2    Batts, K.3    van Hoek, B.4    Ludwig, J.5
  • 17
    • 0023179735 scopus 로고
    • The acute vanishing bile duct syndrome (acute irreversible rejection) after orthotopic liver transplantation
    • Ludwig J, Wiesner RH, Batts KP, Perkins JD, Krom RA. The acute vanishing bile duct syndrome (acute irreversible rejection) after orthotopic liver transplantation. Hepatology 1987; 7: 476-483
    • (1987) Hepatology , vol.7 , pp. 476-483
    • Ludwig, J.1    Wiesner, R.H.2    Batts, K.P.3    Perkins, J.D.4    Krom, R.A.5
  • 18
    • 0035114807 scopus 로고    scopus 로고
    • Hepatic artery thrombosis after orthotopic liver transplantation: a review of nonsurgical causes
    • Pastacaldi S, Teixeira R, Montalto P, Rolles K, Burroughs AK. Hepatic artery thrombosis after orthotopic liver transplantation: a review of nonsurgical causes. Liver Transpl 2001; 7: 75-81
    • (2001) Liver Transpl , vol.7 , pp. 75-81
    • Pastacaldi, S.1    Teixeira, R.2    Montalto, P.3    Rolles, K.4    Burroughs, A.K.5
  • 19
    • 0032529435 scopus 로고    scopus 로고
    • Cytomegalovirus and its association with hepatic artery thrombosis after liver transplantation
    • Madalosso C, de Souza NF Jr, Ilstrup DM, Wiesner RH, Krom RA. Cytomegalovirus and its association with hepatic artery thrombosis after liver transplantation. Transplantation 1998; 66: 294-297
    • (1998) Transplantation , vol.66 , pp. 294-297
    • Madalosso, C.1    de Souza Jr., N.F.2    Ilstrup, D.M.3    Wiesner, R.H.4    Krom, R.A.5
  • 20
    • 36248983615 scopus 로고    scopus 로고
    • Cytomegalovirus disease in solid organ transplant recipients: advances lead to new challenges and opportunities
    • Eid AJ, Razonable RR. Cytomegalovirus disease in solid organ transplant recipients: advances lead to new challenges and opportunities. Current Opinion in Organ Transplantation 2007; 12: 610-617
    • (2007) Current Opinion in Organ Transplantation , vol.12 , pp. 610-617
    • Eid, A.J.1    Razonable, R.R.2
  • 21
    • 34248207692 scopus 로고    scopus 로고
    • Risk factors, clinical characteristics, and outcome of Nocardia infection in organ transplant recipients: a matched case-control study
    • Peleg AY, Husain S, Qureshi ZA, Silveira FP, Sarumi M, Shutt KA, Kwak EJ, Paterson DL. Risk factors, clinical characteristics, and outcome of Nocardia infection in organ transplant recipients: a matched case-control study. Clin Infect Dis 2007; 44: 1307-1314
    • (2007) Clin Infect Dis , vol.44 , pp. 1307-1314
    • Peleg, A.Y.1    Husain, S.2    Qureshi, Z.A.3    Silveira, F.P.4    Sarumi, M.5    Shutt, K.A.6    Kwak, E.J.7    Paterson, D.L.8
  • 24
    • 0032526007 scopus 로고    scopus 로고
    • Clinical significance of viral load in the diagnosis of cytomegalovirus disease after liver transplantation
    • Mendez J, Espy M, Smith TF, Wilson J, Wiesner R, Paya CV. Clinical significance of viral load in the diagnosis of cytomegalovirus disease after liver transplantation. Transplantation 1998; 65: 1477-1481
    • (1998) Transplantation , vol.65 , pp. 1477-1481
    • Mendez, J.1    Espy, M.2    Smith, T.F.3    Wilson, J.4    Wiesner, R.5    Paya, C.V.6
  • 26
    • 35448937998 scopus 로고    scopus 로고
    • An assessment of interactions between hepatitis C virus and herpesvirus reactivation in liver transplant recipients using molecular surveillance
    • Humar A, Washburn K, Freeman R, Paya CV, Mouas H, Alecock E, Razonable RR. An assessment of interactions between hepatitis C virus and herpesvirus reactivation in liver transplant recipients using molecular surveillance. Liver Transpl 2007; 13: 1422-1427
    • (2007) Liver Transpl , vol.13 , pp. 1422-1427
    • Humar, A.1    Washburn, K.2    Freeman, R.3    Paya, C.V.4    Mouas, H.5    Alecock, E.6    Razonable, R.R.7
  • 27
    • 0036589963 scopus 로고    scopus 로고
    • Interactions between cytomegalovirus, human herpesvirus-6, and the recurrence of hepatitis C after liver transplantation
    • Humar A, Kumar D, Raboud J, Caliendo AM, Moussa G, Levy G, Mazzulli T. Interactions between cytomegalovirus, human herpesvirus-6, and the recurrence of hepatitis C after liver transplantation. Am J Transplant 2002; 2: 461-466
    • (2002) Am J Transplant , vol.2 , pp. 461-466
    • Humar, A.1    Kumar, D.2    Raboud, J.3    Caliendo, A.M.4    Moussa, G.5    Levy, G.6    Mazzulli, T.7
  • 30
    • 0036229311 scopus 로고    scopus 로고
    • Impact of human herpesvirus-6 on the frequency and severity of recurrent hepatitis C virus hepatitis in liver transplant recipients
    • Singh N, Husain S, Carrigan DR, Knox KK, Weck KE, Wagener MM, Gayowski T. Impact of human herpesvirus-6 on the frequency and severity of recurrent hepatitis C virus hepatitis in liver transplant recipients. Clin Transplant 2002; 16: 92-96
    • (2002) Clin Transplant , vol.16 , pp. 92-96
    • Singh, N.1    Husain, S.2    Carrigan, D.R.3    Knox, K.K.4    Weck, K.E.5    Wagener, M.M.6    Gayowski, T.7
  • 32
    • 40749108069 scopus 로고    scopus 로고
    • Delayed-onset primary cytomegalovirus disease and the risk of allograft failure and mortality after kidney transplantation
    • Arthurs SK, Eid AJ, Pedersen RA, Kremers WK, Cosio FG, Patel R, Razonable RR. Delayed-onset primary cytomegalovirus disease and the risk of allograft failure and mortality after kidney transplantation. Clin Infect Dis 2008; 46: 840-846
    • (2008) Clin Infect Dis , vol.46 , pp. 840-846
    • Arthurs, S.K.1    Eid, A.J.2    Pedersen, R.A.3    Kremers, W.K.4    Cosio, F.G.5    Patel, R.6    Razonable, R.R.7
  • 35
    • 33644825977 scopus 로고    scopus 로고
    • Metaanalysis: the efficacy of strategies to prevent organ disease by cytomegalovirus in solid organ transplant recipients
    • Kalil AC, Levitsky J, Lyden E, Stoner J, Freifeld AG. Metaanalysis: the efficacy of strategies to prevent organ disease by cytomegalovirus in solid organ transplant recipients. Ann Intern Med 2005; 143: 870-880
    • (2005) Ann Intern Med , vol.143 , pp. 870-880
    • Kalil, A.C.1    Levitsky, J.2    Lyden, E.3    Stoner, J.4    Freifeld, A.G.5
  • 36
    • 33748652453 scopus 로고    scopus 로고
    • Preventing post-organ transplantation cytomegalovirus disease with ganciclovir: a meta-analysis comparing prophylactic and preemptive therapies
    • Small LN, Lau J, Snydman DR. Preventing post-organ transplantation cytomegalovirus disease with ganciclovir: a meta-analysis comparing prophylactic and preemptive therapies. Clin Infect Dis 2006; 43: 869-880
    • (2006) Clin Infect Dis , vol.43 , pp. 869-880
    • Small, L.N.1    Lau, J.2    Snydman, D.R.3
  • 38
    • 0029588684 scopus 로고
    • Long-term ganciclovir prophylaxis eliminates serious cytomegalovirus disease in liver transplant recipients receiving OKT3 therapy for rejection
    • Winston DJ, Imagawa DK, Holt CD, Kaldas F, Shaked A, Busuttil RW. Long-term ganciclovir prophylaxis eliminates serious cytomegalovirus disease in liver transplant recipients receiving OKT3 therapy for rejection. Transplantation 1995; 60: 1357-1360
    • (1995) Transplantation , vol.60 , pp. 1357-1360
    • Winston, D.J.1    Imagawa, D.K.2    Holt, C.D.3    Kaldas, F.4    Shaked, A.5    Busuttil, R.W.6
  • 39
  • 41
  • 42
    • 0034026538 scopus 로고    scopus 로고
    • Mycophenolate mofetil increases cytomegalovirus invasive organ disease in renal transplant patients
    • Sarmiento JM, Dockrell DH, Schwab TR, Munn SR, Paya CV. Mycophenolate mofetil increases cytomegalovirus invasive organ disease in renal transplant patients. Clin Transplant 2000; 14: 136-138
    • (2000) Clin Transplant , vol.14 , pp. 136-138
    • Sarmiento, J.M.1    Dockrell, D.H.2    Schwab, T.R.3    Munn, S.R.4    Paya, C.V.5
  • 45
    • 34248190825 scopus 로고    scopus 로고
    • Relationship between Toll-like receptor 2 polymorphism and cytomegalovirus disease after liver transplantation
    • Kijpittayarit S, Eid AJ, Brown RA, Paya CV, Razonable RR. Relationship between Toll-like receptor 2 polymorphism and cytomegalovirus disease after liver transplantation. Clin Infect Dis 2007; 44: 1315-1320
    • (2007) Clin Infect Dis , vol.44 , pp. 1315-1320
    • Kijpittayarit, S.1    Eid, A.J.2    Brown, R.A.3    Paya, C.V.4    Razonable, R.R.5
  • 46
    • 33847031357 scopus 로고    scopus 로고
    • Longitudinal assessment of cytomegalovirus (CMV)- specific immune responses in liver transplant recipients at high risk for late CMV disease
    • La Rosa C, Limaye AP, Krishnan A, Longmate J, Diamond DJ. Longitudinal assessment of cytomegalovirus (CMV)- specific immune responses in liver transplant recipients at high risk for late CMV disease. J Infect Dis 2007; 195: 633-644
    • (2007) J Infect Dis , vol.195 , pp. 633-644
    • La Rosa, C.1    Limaye, A.P.2    Krishnan, A.3    Longmate, J.4    Diamond, D.J.5
  • 52
    • 33748514365 scopus 로고    scopus 로고
    • Lipopolysaccharide, tumor necrosis factor alpha, or interleukin-1beta triggers reactivation of latent cytomegalovirus in immunocompetent mice
    • Cook CH, Trgovcich J, Zimmerman PD, Zhang Y, Sedmak DD. Lipopolysaccharide, tumor necrosis factor alpha, or interleukin-1beta triggers reactivation of latent cytomegalovirus in immunocompetent mice. J Virol 2006; 80: 9151-9158
    • (2006) J Virol , vol.80 , pp. 9151-9158
    • Cook, C.H.1    Trgovcich, J.2    Zimmerman, P.D.3    Zhang, Y.4    Sedmak, D.D.5
  • 53
    • 0026523675 scopus 로고
    • Prevalence of invasive cytomegalovirus disease with administration of muromonab CD-3 in patients undergoing orthotopic liver transplantation
    • Hooks MA, Perlino CA, Henderson JM, Millikan WJ Jr, Kutner MH. Prevalence of invasive cytomegalovirus disease with administration of muromonab CD-3 in patients undergoing orthotopic liver transplantation. Ann Pharmacother 1992; 26: 617-620
    • (1992) Ann Pharmacother , vol.26 , pp. 617-620
    • Hooks, M.A.1    Perlino, C.A.2    Henderson, J.M.3    Millikan Jr., W.J.4    Kutner, M.H.5
  • 54
    • 0030066247 scopus 로고    scopus 로고
    • Increased infections in liver transplant recipients with recurrent hepatitis C virus hepatitis
    • Singh N, Gayowski T, Wagener MM, Marino IR. Increased infections in liver transplant recipients with recurrent hepatitis C virus hepatitis. Transplantation 1996; 61: 402-406
    • (1996) Transplantation , vol.61 , pp. 402-406
    • Singh, N.1    Gayowski, T.2    Wagener, M.M.3    Marino, I.R.4
  • 55
    • 0034631463 scopus 로고    scopus 로고
    • Application of viral-load kinetics to identify patients who develop cytomegalovirus disease after transplantation
    • Emery VC, Sabin CA, Cope AV, Gor D, Hassan-Walker AF, Griffiths PD. Application of viral-load kinetics to identify patients who develop cytomegalovirus disease after transplantation. Lancet 2000; 355: 2032-2036
    • (2000) Lancet , vol.355 , pp. 2032-2036
    • Emery, V.C.1    Sabin, C.A.2    Cope, A.V.3    Gor, D.4    Hassan-Walker, A.F.5    Griffiths, P.D.6
  • 57
    • 33644648365 scopus 로고    scopus 로고
    • Cytomegalovirus infection in solid organ transplant recipients: new challenges and their implications for preventive strategies
    • Singh N. Cytomegalovirus infection in solid organ transplant recipients: new challenges and their implications for preventive strategies. J Clin Virol 2006; 35: 474-477
    • (2006) J Clin Virol , vol.35 , pp. 474-477
    • Singh, N.1
  • 59
    • 12344298316 scopus 로고    scopus 로고
    • Efficacy of valganciclovir administered as preemptive therapy for cytomegalovirus disease in liver transplant recipients: impact on viral load and late-onset cytomegalovirus disease
    • Singh N, Wannstedt C, Keyes L, Gayowski T, Wagener MM, Cacciarelli TV. Efficacy of valganciclovir administered as preemptive therapy for cytomegalovirus disease in liver transplant recipients: impact on viral load and late-onset cytomegalovirus disease. Transplantation 2005; 79: 85-90
    • (2005) Transplantation , vol.79 , pp. 85-90
    • Singh, N.1    Wannstedt, C.2    Keyes, L.3    Gayowski, T.4    Wagener, M.M.5    Cacciarelli, T.V.6
  • 60
    • 0034666047 scopus 로고    scopus 로고
    • Cytomegalovirus antigenemia directed pre-emptive prophylaxis with oral versus I.V. ganciclovir for the prevention of cytomegalovirus disease in liver transplant recipients: a randomized, controlled trial
    • Singh N, Paterson DL, Gayowski T, Wagener MM, Marino IR. Cytomegalovirus antigenemia directed pre-emptive prophylaxis with oral versus I.V. ganciclovir for the prevention of cytomegalovirus disease in liver transplant recipients: a randomized, controlled trial. Transplantation 2000; 70: 717-722
    • (2000) Transplantation , vol.70 , pp. 717-722
    • Singh, N.1    Paterson, D.L.2    Gayowski, T.3    Wagener, M.M.4    Marino, I.R.5
  • 61
    • 33244489841 scopus 로고    scopus 로고
    • Preemptive therapy for cytomegalovirus
    • Singh N, Yu VL. Preemptive therapy for cytomegalovirus. Liver Transpl 2006; 12: 327
    • (2006) Liver Transpl , vol.12 , pp. 327
    • Singh, N.1    Yu, V.L.2
  • 62
    • 72949103510 scopus 로고    scopus 로고
    • Cytomegalovirus in solid organ transplant recipients
    • Humar A, Snydman D. Cytomegalovirus in solid organ transplant recipients. Am J Transplant 2009; 9 Suppl 4: S78-S86
    • (2009) Am J Transplant , vol.9 , Issue.SUPPL. 4
    • Humar, A.1    Snydman, D.2
  • 66
    • 39449093095 scopus 로고    scopus 로고
    • Valganciclovir as preemptive therapy for cytomegalovirus in cytomegalovirusseronegative liver transplant recipients of cytomegalovirusseropositive donor allografts
    • Singh N, Wannstedt C, Keyes L, Mayher D, Tickerhoof L, Akoad M, Wagener MM, Cacciarelli TV. Valganciclovir as preemptive therapy for cytomegalovirus in cytomegalovirusseronegative liver transplant recipients of cytomegalovirusseropositive donor allografts. Liver Transpl 2008; 14: 240-244
    • (2008) Liver Transpl , vol.14 , pp. 240-244
    • Singh, N.1    Wannstedt, C.2    Keyes, L.3    Mayher, D.4    Tickerhoof, L.5    Akoad, M.6    Wagener, M.M.7    Cacciarelli, T.V.8
  • 67
    • 0034046010 scopus 로고    scopus 로고
    • Comparison of quantitative cytomegalovirus (CMV) PCR in plasma and CMV antigenemia assay: clinical utility of the prototype AMPLICOR CMV MONITOR test in transplant recipients
    • Caliendo AM, St George K, Kao SY, Allega J, Tan BH, LaFontaine R, Bui L, Rinaldo CR. Comparison of quantitative cytomegalovirus (CMV) PCR in plasma and CMV antigenemia assay: clinical utility of the prototype AMPLICOR CMV MONITOR test in transplant recipients. J Clin Microbiol 2000; 38: 2122-2127
    • (2000) J Clin Microbiol , vol.38 , pp. 2122-2127
    • Caliendo, A.M.1    St George, K.2    Kao, S.Y.3    Allega, J.4    Tan, B.H.5    LaFontaine, R.6    Bui, L.7    Rinaldo, C.R.8
  • 68
    • 20444453778 scopus 로고    scopus 로고
    • Antiviral medications to prevent cytomegalovirus disease and early death in recipients of solid-organ transplants: a systematic review of randomised controlled trials
    • Hodson EM, Jones CA, Webster AC, Strippoli GF, Barclay PG, Kable K, Vimalachandra D, Craig JC. Antiviral medications to prevent cytomegalovirus disease and early death in recipients of solid-organ transplants: a systematic review of randomised controlled trials. Lancet 2005; 365: 2105-2115
    • (2005) Lancet , vol.365 , pp. 2105-2115
    • Hodson, E.M.1    Jones, C.A.2    Webster, A.C.3    Strippoli, G.F.4    Barclay, P.G.5    Kable, K.6    Vimalachandra, D.7    Craig, J.C.8
  • 69
    • 19544388919 scopus 로고    scopus 로고
    • Indirect outcomes associated with cytomegalovirus (opportunistic infections, hepatitis C virus sequelae, and mortality) in liver-transplant recipients with the use of preemptive therapy for 13 years
    • Singh N, Wannstedt C, Keyes L, Wagener MM, Gayowski T, Cacciarelli TV. Indirect outcomes associated with cytomegalovirus (opportunistic infections, hepatitis C virus sequelae, and mortality) in liver-transplant recipients with the use of preemptive therapy for 13 years. Transplantation 2005; 79: 1428-1434
    • (2005) Transplantation , vol.79 , pp. 1428-1434
    • Singh, N.1    Wannstedt, C.2    Keyes, L.3    Wagener, M.M.4    Gayowski, T.5    Cacciarelli, T.V.6
  • 70
    • 0029065431 scopus 로고
    • Randomised comparison of ganciclovir and high-dose acyclovir for longterm cytomegalovirus prophylaxis in liver-transplant recipients
    • Winston DJ, Wirin D, Shaked A, Busuttil RW. Randomised comparison of ganciclovir and high-dose acyclovir for longterm cytomegalovirus prophylaxis in liver-transplant recipients. Lancet 1995; 346: 69-74
    • (1995) Lancet , vol.346 , pp. 69-74
    • Winston, D.J.1    Wirin, D.2    Shaked, A.3    Busuttil, R.W.4
  • 72
    • 0037467792 scopus 로고    scopus 로고
    • Randomized controlled trial of oral ganciclovir versus oral acyclovir after induction with intravenous ganciclovir for long-term prophylaxis of cytomegalovirus disease in cytomegalovirus-seropositive liver transplant recipients
    • Winston DJ, Busuttil RW. Randomized controlled trial of oral ganciclovir versus oral acyclovir after induction with intravenous ganciclovir for long-term prophylaxis of cytomegalovirus disease in cytomegalovirus-seropositive liver transplant recipients. Transplantation 2003; 75: 229-233
    • (2003) Transplantation , vol.75 , pp. 229-233
    • Winston, D.J.1    Busuttil, R.W.2
  • 73
    • 2942589046 scopus 로고    scopus 로고
    • Valganciclovir for the prevention and treatment of cytomegalovirus disease in immunocompromised hosts
    • Razonable RR, Paya CV. Valganciclovir for the prevention and treatment of cytomegalovirus disease in immunocompromised hosts. Expert Rev Anti Infect Ther 2004; 2: 27-41
    • (2004) Expert Rev Anti Infect Ther , vol.2 , pp. 27-41
    • Razonable, R.R.1    Paya, C.V.2
  • 75
    • 0036789258 scopus 로고    scopus 로고
    • Ganciclovir-resistant cytomegalovirus in organ transplant recipients
    • Limaye AP. Ganciclovir-resistant cytomegalovirus in organ transplant recipients. Clin Infect Dis 2002; 35: 866-872
    • (2002) Clin Infect Dis , vol.35 , pp. 866-872
    • Limaye, A.P.1
  • 77
    • 26444437323 scopus 로고    scopus 로고
    • Does valganciclovir hydrochloride (valcyte) provide effective prophylaxis against cytomegalovirus infection in liver transplant recipients?
    • Jain A, Orloff M, Kashyap R, Lansing K, Betts R, Mohanka R, Menegus M, Ryan C, Bozorgzadeh A. Does valganciclovir hydrochloride (valcyte) provide effective prophylaxis against cytomegalovirus infection in liver transplant recipients? Transplant Proc 2005; 37: 3182-3186
    • (2005) Transplant Proc , vol.37 , pp. 3182-3186
    • Jain, A.1    Orloff, M.2    Kashyap, R.3    Lansing, K.4    Betts, R.5    Mohanka, R.6    Menegus, M.7    Ryan, C.8    Bozorgzadeh, A.9
  • 81
    • 0034050770 scopus 로고    scopus 로고
    • Cytomegalovirus (CMV) DNA load predicts relapsing CMV infection after solid organ transplantation
    • Sia IG, Wilson JA, Groettum CM, Espy MJ, Smith TF, Paya CV. Cytomegalovirus (CMV) DNA load predicts relapsing CMV infection after solid organ transplantation. J Infect Dis 2000; 181: 717-720
    • (2000) J Infect Dis , vol.181 , pp. 717-720
    • Sia, I.G.1    Wilson, J.A.2    Groettum, C.M.3    Espy, M.J.4    Smith, T.F.5    Paya, C.V.6
  • 83
    • 38649114995 scopus 로고    scopus 로고
    • Clinical features and outcomes of cytomegalovirus retinitis after transplantation
    • Eid AJ, Bakri SJ, Kijpittayarit S, Razonable RR. Clinical features and outcomes of cytomegalovirus retinitis after transplantation. Transpl Infect Dis 2008; 10: 13-18
    • (2008) Transpl Infect Dis , vol.10 , pp. 13-18
    • Eid, A.J.1    Bakri, S.J.2    Kijpittayarit, S.3    Razonable, R.R.4
  • 84
    • 36248953571 scopus 로고    scopus 로고
    • Valganciclovir for the treatment of cytomegalovirus retinitis in patients with AIDS
    • Eid AJ, Razonable RR. Valganciclovir for the treatment of cytomegalovirus retinitis in patients with AIDS. Expert Review of Ophthalmology 2007; 2: 351-361
    • (2007) Expert Review of Ophthalmology , vol.2 , pp. 351-361
    • Eid, A.J.1    Razonable, R.R.2
  • 85
    • 72549111679 scopus 로고    scopus 로고
    • Clinical predictors of relapse after treatment of primary gastrointestinal cytomegalovirus disease in solid organ transplant recipients
    • Eid AJ, Arthurs SK, Deziel PJ, Wilhelm MP, Razonable RR. Clinical predictors of relapse after treatment of primary gastrointestinal cytomegalovirus disease in solid organ transplant recipients. Am J Transplant 2010; 10: 157-161
    • (2010) Am J Transplant , vol.10 , pp. 157-161
    • Eid, A.J.1    Arthurs, S.K.2    Deziel, P.J.3    Wilhelm, M.P.4    Razonable, R.R.5
  • 86
    • 0036900551 scopus 로고    scopus 로고
    • Antiviral resistance in cytomegalovirus: an emerging problem in organ transplant recipients
    • Limaye AP. Antiviral resistance in cytomegalovirus: an emerging problem in organ transplant recipients. Semin Respir Infect 2002; 17: 265-273
    • (2002) Semin Respir Infect , vol.17 , pp. 265-273
    • Limaye, A.P.1
  • 87
    • 34250795232 scopus 로고    scopus 로고
    • Cytomegalovirus UL97 kinase mutations that confer maribavir resistance
    • Chou S, Wechel LC, Marousek GI. Cytomegalovirus UL97 kinase mutations that confer maribavir resistance. J Infect Dis 2007; 196: 91-94
    • (2007) J Infect Dis , vol.196 , pp. 91-94
    • Chou, S.1    Wechel, L.C.2    Marousek, G.I.3
  • 88
    • 47649088674 scopus 로고    scopus 로고
    • Cytomegalovirus UL97 mutations in the era of ganciclovir and maribavir
    • Chou S. Cytomegalovirus UL97 mutations in the era of ganciclovir and maribavir. Rev Med Virol 2008; 18: 233-246
    • (2008) Rev Med Virol , vol.18 , pp. 233-246
    • Chou, S.1
  • 89
    • 41049108271 scopus 로고    scopus 로고
    • Emergence of drug-resistant cytomegalovirus in the era of valganciclovir prophylaxis: therapeutic implications and outcomes
    • Eid AJ, Arthurs SK, Deziel PJ, Wilhelm MP, Razonable RR. Emergence of drug-resistant cytomegalovirus in the era of valganciclovir prophylaxis: therapeutic implications and outcomes. Clin Transplant 2008; 22: 162-170
    • (2008) Clin Transplant , vol.22 , pp. 162-170
    • Eid, A.J.1    Arthurs, S.K.2    Deziel, P.J.3    Wilhelm, M.P.4    Razonable, R.R.5
  • 91
    • 34248164508 scopus 로고    scopus 로고
    • Maribavir: 1263W94, Benzimidavir, GW 1263, GW 1263W94, VP41263
    • Maribavir: 1263W94, Benzimidavir, GW 1263, GW 1263W94, VP41263. Drugs R D 2007; 8: 188-192
    • (2007) Drugs R D , vol.8 , pp. 188-192


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.